Asthma vs COPD Asthma COPD -FEV1 improves by 12% or more with

Slides:



Advertisements
Similar presentations
ABCDABCD mMRC < 2 CAT 2 CAT > >2>2 RISK GOLD RISK Exacerbation TypeCharatteristicSpirometric classification Exacerbation Per.
Advertisements

STATUS ASTHMATICUS Sigrid Hahn, MD Andy Jagoda, MD, FACEP Department of Emergency Medicine Mount Sinai School of Medicine New York, New York.
Pediatric Asthma: Navigating Through Guidelines and Black Boxes Vinit K. Mahesh, M.D.
Chronic Disease Management Respiratory & CKD Liz Borlase Brampton Medical Practice.
Pneumonia, Empyema, and TB Meira Louis Margriet Greidanus.
Oxygen for IPF Simon Johnson. What is oxygen for? Oxygen is needed to generate energy for all body functions –Muscles walking, lifting, dressing etc.
Nikola Bla ž evi ć Mentor: A. Ž mega č Horvat. - inflammation of the lungs caused by infection - many different causes: bacteria, viruses, fungi, idiopathic.
How Do I Think About Pneumonia? Resident’s Thursday School 07/25/2013 J Rush Pierce Jr, MD, MPH Division of Hospital Medicine, UNM.
Pneumonia Why do we need to know about it? Long recognized as a major cause of death, Pneumonia has been studied intensively since late 1800s. Despite.
IDSA/ATS Guidelines on Community-Acquired Pneumonia in Adults
Pam Charity, MD Cathryn Caton, MD, MS.  Define pneumonia  Review criteria for diagnosis  Review criteria for admission  Review treatment options.
PATIENT TYPEETIOLOGY OutpatientStreptococcus pneumoniae Mycoplasma pneumoniae Haemophilus influenzae Chlamydophila pneumoniae Respiratory viruses* Non-ICU.
Acute severe asthma.
Pneumonia Michele Ritter, M.D. Argy – Feb Pneumonia – Definition An acute infection of the pulmonary parenchyma that is associated with at least.
COPD MANAGEMENT FALLS SHORT AT RCRMC Jean Solomon, M.D.
COPD Joshua Jewell. Epidemiology 8% of all individuals 10% age >40 6 th leading cause of death worldwide th in U.S. - >120,000 Expected 3 rd 2020.
Chronic obstructive pulmonary disease (COPD) Professor Bill MacNee
22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.
Chronic Obstructive Pulmonary Disease and Asthma: All That Wheezes? Clifford Courville, MD Pulmonary, Allergy, and Critical Care.
COPD Management of Stable COPD Shyam Rao May 2014.
1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.
British Guideline on the Management of Asthma. Aims Review of current SIGN/BTS guidelines –Diagnosing Asthma –Stepwise management of Asthma –Managing.
Approach to bronchiectasis
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
COPD AS Systemic disease BY Dr/Sami EL-Dahdouh (MD) Lecturer of Pulmonary & Critical care Faculty of Medicine, Menofia University.
Clinical Cases Beta-Lactam Answers. Case 1 What antibiotic would you recommend for intravenous therapy in a 40yo BM with a Staphylococcus aureus (MSSA)
Matt Wong + Sheila Murphy Dec 13 th  AKT MINI EXAM  NICE – COPD GUIDELINES  BTS ASTHMA GUIDELINES  INHALER TECHNIQUE  QOF  SPIROMETRY  CSA.
Using Nursing Home Antibiograms To Improve Antibiotic Prescribing and Delivery Training Slides for Prescribing Clinicians Comprehensive Antibiogram Toolkit.
Respiratory COPD/Asthma.
MANAGEMENT OF ASTHMA 6 Penaflor, Dominic Quinto, Milraam Ramos,Josefa Victoria Sicat, Gracie Suaco, David Tio- Cuizon, Jeremiah Valenzuela, Virginia Lou.
Assessing Control & Adjusting Therapy in Youths > 12 Years of Age & Adults *ACQ values of 0.76–1.4 are indeterminate regarding well-controlled asthma.
What would be the most usual abnormal PE finding among asthma suspects? A. Wheezing on auscultation B. Wheezing only on forcible exhalation C. Absence.
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Common ID Syndromes March 2014.
Component 4 Medications.
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Chronic Obstructive Pulmonary Disease Austin Paul K.
Breathless Patient Aaqid Akram MBChB (2013) Clinical Education Fellow.
© IPCRG 2007 COPD -Management of stable disease WONCA meeting Istanbul October 2015 Svein Høegh Henrichsen Oslo, Norway.
Asthma vs COPD Asthma COPD -FEV1 improves by 12% or more with
Severe breathlessness
Community Acquired Pneumonia (CAP)
Component 4 Medications. Key Points - Medications  2 general classes: – Long-term control medications – Quick-Relief medications  Controller medications:
Picking up the Clues Bert the breathless patient….. March 2015 GL/XBR/0315/0356.
Picking up the Clues Bert the breathless patient….. Date of Preparation: Mar 2015 GL/XBR/0315/0356.
History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.
ASTHMA MANAGEMENT AND PREVENTION PREFACE Asthma affects an estimated 300 million individuals worldwide. Serious global health problem affecting all age.
Asthma Guidelines, Diagnosis and Management Alison Hughes Respiratory Specialist Nurse Solent NHS Trust.
Attaran D, Mashhad university of medical sciences.
ASTHMA Definition: Asthma is a chronic lung disease due to inflammation of the airways resulted into airway obstruction. The obstruction is reversible.
Community-Acquired Pneumonia Richard G. Wunderink, M.D., and Grant W. Waterer, M.B., B.S., Ph.D. N Engl J Med 2014;370: R3 김선혜 /Prof. 박명재 1.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
COPD Emergency Department Junior Medical Staff Teaching August 2015.
PNEUMONIA DR. FAWAD AHMAD RANDHAWA M.B.B.S. ( KING EDWARD MEDICAL COLLEGE) M.C.P.S; F.C.P.S. ( MEDICINE) F.C.P.S. ( ENDOCRINOLOGY) ASSISTANT PROFESSOR.
Therapeutics 3 Tutoring
Respiratory System Disorders
COPD – Primary Care Update
Management of Chronic Airflow Obstruction
Therapeutics III Tutoring February 10th, 2016
More Antibiotics Tutoring
COPD Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA.
More Antibiotics Tutoring
COPD By Alaina Darby.
Monitoring asthma in primary care
CAP Therapy Babak Sayad Associate Professor of Infectious Diseases
COPD Exacerbation (1) C.L.I.P.S.
Management of Chronic Stable COPD
The efficacy and safety of omalizumab in pediatric allergic asthma
And WHY does it matter which label?
Presentation transcript:

Asthma vs COPD Asthma COPD -FEV1 improves by 12% or more with Beta2 agonist -Cough is Non-Productive -Cough worse at night & early AM -triggered by allergies/environment -Asthma is reversible - NORMAL VALUES -FEV1= normal is >= 80% FVC=Empty 80% lungs in < 6 seconds FEV1/FVC-75-85% COPD - Cough all the time -Assoc with smoking -Not reversible -FEV1/FVC < 70%

MMRC Dyspneic Scale (Modified Medical Research Council) 0 --- only gets breathless with Streneous Exercise 1--- SOA when hurrying on level ground or hill 2--- Walk slower than people your age. 3--- Stop for breath about 100 yards or a few minutes 4--- Too breathless to leave house or dress.

CAT-SCORES (copd) Never cough ------------------------ 0 thru 5 Cough all the time Never have phlegm (mucous) ---0 thru 5 Chest completely full of mucous Chest is not tight ----------------- 0 thru 5 Chest feels very tight Stairs/hill-not breathless --------- 0 thru 5 hill/stairs- very breathless Not limited with home activities 0 thru 5 Very limited Confident leaving home ----------- 0 thru 5 Not confident leaving home Sleep soundly -------------------------0 thru 5 Don’t sleep soundly Lost of energy ------------------------ 0 thru 5 No energy at all COPD guidelines= CAT <10 or >=10 A < 10 B >=10 C < 10 D >=10 (COPD Categories A,B,C,D)

COPD GLD GUIDELINES A … <=1 exac/yr FEV >=80% mmr=0-1 Cat <10- SABA PRN B <=1 exac/yr FEV1 50-80% MMR>=2 CAT<10- LABA & SABA PRN OR LA anticholinergics C >=2 exac/yr FEV 30-50% MMR 0-1 CAT <10 ICS + LABA or LA anticholinergic D >=2 exac/yr FEV < 30% MMR >=2 CAT >=10 ICS + LABAQ and/or Anticholinergic FEV1 <50% use steroids If incr dyspnea = refluokost(DALIRESP)

Asthma Severity Control 4 types Frequency Nite-time FEV1/FVC FEV1 Intermittent SABA PRN <=2x/wk < 2x/month Normal >80% Mild Persistant Low dose ICS alt: singulair or cromolyn >2x/week (but not daily) 3-4 x/month Mod Persist Low dose ICS & LABA or theophy/steroi Daily > 1x/week Not nightly 5% 60-80% Severe Persist Oral steroids/ics/+ LTM or theo May add spiriva Throughout The day 7 nits/week >5% < 60%

Curb-65 score Confusion BUN > 19 RR > 30 BP < 90/60 Age > 65 Curb score risk death 30 d location 0 0.7% outpt 2.1% out/in pt 9.2% inpt 14.5% inpt 40% inpt 57% inpt Curb = 1 .. Tx outpt Curb >1 .. Inpt Curb 4-5 . ICU

Hypoxia --- All or part of body cannot use or receive oxygen—anemic, Hypoxemia- Reduction in the concentration of oxygen in the arterial blood Oxygen dissolve in blood ….. 1.5% PaO2 Oxygen bound to Hgb……….. 98.5% SpO2 (pulse ox) Aa gradient …. PAO2 – PaO2 Normal A-a-gradient = (age/4) + 4 … incr with age PAo2= 150- (PaCo2/0.8)

COPD Antibiotic Selection INDICATION: 1.0 Increase Dyspnea 2.0 Increase Sputum 3.0 Sputum Purulence BACTERIA IS USUALLY Moraxella Catarrhalic Haemophilus Influenza Strept Pneumo (pt >3 exacerb/yr _ FEV1 <50%.. Suspect pseudomonas AB selection: 2nd line med eg: zithromycin, doxy DURATION: 5 days (use to be 10-14)

CAP (outpt) Cap= no more than 2 days hospitalized in past 90 days, not a NH-resident, no iv ab, no chemo, no wound cure, EMPIRIC ---- Macrolid or Doxycycline With CoMorbidities (COPD, DM, CRF, CHF, CA,, --- levaquin 750mg or ---- amoxil 1gm tid or augmentin 2gm id PLUS Azithromycin or doxycycline

CAP (Inpatient) EMPIRIC - Levaquin 750mg - Ampicillin, rocephin PLUS macrolide or doxycycline ICU unasyn PLUS Quinolone or Azithromycin rocephin PLUS Quinolone or Azithromycin Cefotaxime Plus Qquinolone or azithromycin TREATMENT – AT LEAST 5 DAYS, MUST BE FEBRILE X 48 HOURS.

HCAP (Inpt) HCAP – ab within past 5 days, hosp of 5 days or more, hosp 2 days or more in past 90 days, home infusion, HD in 30 days, home wound care, family member w MDR, immunosuppresant Hospital Stay < 5 days - 3rd generation cephalosporin - Quinolone - Unasyn - Ertapenem Hospital Stay > 5 days (need 2 drugs to cover pseudomonas) -- Ceftazidime or cefepime PLUS QUINOLONE OR AMINOGLYCOSIDE --Carbapenem PLUS QUINOLONE OR AMINOGLYCOSIDE --Zosyn PLUS QUINOLONE OR AMINOGLYCOSIDE --add van or linezolid if suspect mrsa